跳至主要内容
临床试验/IRCT20220601055051N1
IRCT20220601055051N1尚未招募3 期

Effect of an herbal nasal spray (an Iranian traditional medicine drug) based on oregano on migraine: A randomized, double-blinded, clinical trial

Tehran University of Medical Sciences0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Migraine based on IHS criteria
  • 2 to 8 migraine attack in a month with less than 15 days headache a month and with at least 48 hours intervals
  • Onset of headaches less than one year ago
  • No warm brain temperament
  • 18 to 65 years old with headache onset no later than 50 years old

排除标准

  • Secondary headaches
  • Regular use of antipsychotic or antidepressant drugs during last 3 months for reasons other than migraine
  • Alcohol or drug abuse
  • Drug sensitivity to the drug ingredients
  • Fertile women with no contraception
  • Pregnancy and breast feeding
  • consuming drugs affecting migraine headache or interacting with drug ingredients during last week
  • Analgesic overuse based on IHS criteria
  • Severe physical or psychologic disease

研究者

相似试验